Screener
Aquestive Therapeutics, Inc. AQST Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:08 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000030
FAQ
- What is Aquestive Therapeutics, Inc.'s price / sales?
- Aquestive Therapeutics, Inc. (AQST) reported price / sales of 10.1× in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s price / sales changed year-over-year?
- Aquestive Therapeutics, Inc.'s price / sales increased by 90.5% year-over-year, from 5.3× to 10.1×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s price / sales?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s price / sales has grown at a 30.4% compound annual growth rate (CAGR), from 4.7× to 17.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Aquestive Therapeutics, Inc.'s price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude